Mriglobal
UEI HKQHNFKNKL15 · MO · subsidiary of Mriglobal · SAM.gov record ↗
$51.7M
FY2025 obligations
31
Contract awards
Jul 18, 2014
First action
Sep 22, 2025
Latest action
Obligations by agency
- Department Of Defense$21.0M
- Department Of Health And Human Services$15.1M
- Environmental Protection Agency$13.0M
- Department Of Agriculture$1.8M
- Department Of The Interior$740K
- General Services Administration$3K
- Department Of Homeland Security$0
Obligations by NAICS
Monthly obligations
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Contracts ending within 18 months (recompete watch)
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75A50123F61001 ↗ | BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES | Office Of Assistant Secretary For Preparedness And Response | 541714 | $34K | Jul 20, 2023 | Jul 19, 2026 |
| 75N91024F00001 ↗ | THE SCOPE OF THIS TASK ORDER IS (1). PRODUCTION OF A DRUG SUBSTANCE, (2) CONVERSION OF DRUG SUBSTANCE TO DRUG PRODUCT, (3) FILLING DRUG PRODUCT INTO APPLICATORS TO BE USED IN THE CLINICAL TRIALS, AND (4) PRODUCTION OF A PLACEBO PRODUCT. | National Institutes Of Health | 541690 | $0 | Sep 18, 2024 | Sep 17, 2026 |
| 75N95024F00002 ↗ | EXERCISE OPTIONS 1,2,3,4 | National Institutes Of Health | 325411 | $137K | Sep 30, 2024 | Sep 29, 2026 |
| 75N91023F00001 ↗ | CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT | National Institutes Of Health | 541690 | $5.4M | Jul 1, 2023 | Dec 28, 2026 |
| 75N95019F00088 ↗ | TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2020 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2025, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. | National Institutes Of Health | 325412 | $-13K | Sep 16, 2019 | Jan 31, 2027 |
| 75N91025F00001 ↗ | MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE | National Institutes Of Health | 541690 | $3.5M | Sep 22, 2025 | Sep 21, 2027 |
| 75N91024F00002 ↗ | MANUFACTURE OF PLASMID DNA DRUG SUBSTANCE AND DRUG PRODUCT | National Institutes Of Health | 541690 | $0 | Sep 25, 2024 | Sep 24, 2027 |
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| FA807524F0027 ↗ | INFORMATION ANALYSIS CENTER MULTIPLE AWARD CONTRACT TASK ORDER PERFORMANCE WORK STATEMENT (PWS) RESEARCH, DEVELOPMENT, TEST AND EVALUATION FOR THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE | Department Of The Air Force | 541715 | $16.4M | Jul 15, 2024 | Jul 14, 2029 |
| 68HERH25C0005 ↗ | PORTABLE HIGH THROUGHPUT INTEGRATED LABORATORY IDENTIFICATION SYSTEMS (PHILIS) PLATFORM MODERNIZATION 2.0 | Environmental Protection Agency | 336211 | $13.0M | Jan 22, 2025 | Jan 21, 2026 |
| 75N91023F00001 ↗ | CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT | National Institutes Of Health | 541690 | $5.4M | Jul 1, 2023 | Dec 28, 2026 |
| HQ003422C0090 ↗ | CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR LABORATORY SUPPORT SERVICES | Washington Headquarters Services | 541380 | $5.3M | Aug 29, 2022 | Jun 28, 2026 |
| 75N91025F00001 ↗ | MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE | National Institutes Of Health | 541690 | $3.5M | Sep 22, 2025 | Sep 21, 2027 |
| HHSN273201400020C ↗ | CONTRACT EXTENSION, EXERCISE OP12 | National Institutes Of Health | 541712 | $3.1M | Jul 18, 2014 | Jan 17, 2026 |
| 12639525F0155 ↗ | NBAF CURRICULA DEVELOPMENT QM, TABLETOP, VIDEOS AND SDS | Animal And Plant Health Inspection Service | 611430 | $1.8M | Nov 27, 2024 | Nov 26, 2025 |
| 75N93024C00002 ↗ | MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA) | National Institutes Of Health | 541715 | $1.7M | Nov 17, 2023 | Nov 16, 2025 |
| 75N95023F00001 ↗ | SLAUGENHAUPT-MGH DMFP FOR BPN36964 (PTC680) | National Institutes Of Health | 325412 | $1.1M | Sep 19, 2023 | Sep 18, 2029 |
| 140D0425P0205 ↗ | THE PURPOSE OF THIS REQUIREMENT IS TO CONTRACT FOR API AND DILUENT | Departmental Offices | 325412 | $740K | Sep 16, 2025 | Sep 19, 2028 |
| 75N93022F00001 ↗ | RESEARCH AND DEVELOPMENT PRODUCT STORAGE AND SHIPPING | National Institutes Of Health | 541715 | $398K | Dec 1, 2021 | Nov 30, 2025 |
| 75N91023F00001 ↗ | EVALUATION OF SHELF-LIFE OF SAMPLES OF INVESTIGATIONAL CLINICAL DRUG FORMULATIONS, TO INCLUDE PARENTERAL, ORAL, AND OTHER TYPES OF DOSAGE FORMS. | National Institutes Of Health | 325412 | $159K | Aug 1, 2023 | Jan 31, 2026 |
| 75N95024F00002 ↗ | EXERCISE OPTIONS 1,2,3,4 | National Institutes Of Health | 325411 | $137K | Sep 30, 2024 | Sep 29, 2026 |
| 75A50123F61001 ↗ | BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES | Office Of Assistant Secretary For Preparedness And Response | 541714 | $34K | Jul 20, 2023 | Jul 19, 2026 |
| 75D30125D20639 ↗ | DIAGNOSTIC TESTING IDIQ | Centers For Disease Control And Prevention | 541380 | $10K | Sep 29, 2025 | — |
| 47QRCA25DU229 ↗ | ONE ACQUISITION SOLUTION FOR INTEGRATED SERVICES PLUS (OASIS+) UNRESTRICTED MULTIPLE AGENCY CONTRACT (MAC) | Federal Acquisition Service | 541690 | $3K | Dec 17, 2024 | — |
| 70RDAD21D00000001 ↗ | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION PERIOD FOUR. | Office Of Procurement Operations | 325413 | $0 | Nov 6, 2020 | — |
| 70RWMD23C00000023 ↗ | DOGE COST EFFICIENCY EO EXCLUSION SECTION 2(D). THE PURPOSE OF THIS MODIFICATION IS TO RESCOPE THE STATEMENT OF WORK TO INCLUDE REPLACING THE PRINCIPAL INVESTIGATOR WITH JOSEPH A. RUSSELL AT NO COST TO THE GOVERNMENT. | Office Of Procurement Operations | 541715 | $0 | Sep 29, 2023 | Nov 28, 2025 |
| 75N91023D00010 ↗ | IDIQ CONTRACT FOR CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT SERVICES | National Institutes Of Health | 541690 | $0 | Jul 1, 2023 | — |
| FA807518D0017 ↗ | DEPARTMENT OF DEFENSE INFORMATION ANALYSIS CENTER MULTIPLE AWARD CONTRACT | Department Of The Air Force | 541715 | $0 | Sep 27, 2018 | — |
| W911QY18D0115 ↗ | RESEARCH, DEVELOPMENT, ACQUISITION AND PROCUREMENT OF CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE SYSTEMS | Department Of The Army | 541715 | $0 | Nov 1, 2017 | — |
| 75N91024F00001 ↗ | THE SCOPE OF THIS TASK ORDER IS (1). PRODUCTION OF A DRUG SUBSTANCE, (2) CONVERSION OF DRUG SUBSTANCE TO DRUG PRODUCT, (3) FILLING DRUG PRODUCT INTO APPLICATORS TO BE USED IN THE CLINICAL TRIALS, AND (4) PRODUCTION OF A PLACEBO PRODUCT. | National Institutes Of Health | 541690 | $0 | Sep 18, 2024 | Sep 17, 2026 |
| 75N91024F00002 ↗ | MANUFACTURE OF PLASMID DNA DRUG SUBSTANCE AND DRUG PRODUCT | National Institutes Of Health | 541690 | $0 | Sep 25, 2024 | Sep 24, 2027 |
| 75N95024D00022 ↗ | SAFETY EVALUATION AND TOXICOLOGY STUDIES AND RELATED SERVICES FOR DRUG DEVELOPMENT | National Institutes Of Health | 541715 | $0 | Jun 20, 2024 | — |
| 75A50323C00031 ↗ | THE CONTRACTOR SHALL BE CAPABLE OF COMPLETING ALL NECESSARY DESIGN, FABRICATION, TESTING, AND DELIVERY OF ALL BIOCONTAINMENT UNITS. | Office Of Assistant Secretary For Preparedness And Response | 541715 | $0 | Sep 30, 2023 | Mar 28, 2025 |